Purchase Order 75N94018P00548
Award Date 8/10/18
Potential Completion Date 10/5/18
Potential Value $18K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Exton, PA 19341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a purchase order to Frontage Laboratories, Inc. for $222,500 on July 21, 2026, under a Total Small Business set-aside. Work is performed in Exton, Pennsylvania. The order is firm fixed price with an ultimate completion date of July 20, 2027.</p>
- This is a $117,000.00 firm fixed price purchase order awarded to Frontage Laboratories, Inc. by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The contract is for Frontage Laboratories to provide a range of preclinical research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
- This is a $34,000.00 firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for an intravaginal female fertility study. The contract will run through January 5, 2024. Frontage Laboratories has previously conducted a range of preclinical research services for NIDDK and the National Center for Advancing Translational Sciences, including...
- The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Pace Analytical Life Sciences LLC a $25,918.75 firm fixed price purchase order. This replacement award will provide laboratory testing services to replace a previous contract with Meridian Biogroup under the NIH's research programs. As the prime contractor, Pace Analytical will perform the work itself from its facility in Pine Springs, Minnesota. No subcontractors or set aside...
- This federal contract award is for the synthesis of Fmoc-thyclotide monomers, placed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with the prime contractor Frontage Laboratories, Inc. The $45,500.00 firm-fixed-price purchase order has an ultimate completion date of December 31, 2020. Frontage Laboratories, a minority-owned, Asian-Pacific American-owned business, has an established history of providing specialized research services to NIDDK and other NIH...
- The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $90,000.00 firm fixed price purchase order contract to Frontage Laboratories, Inc. for the synthesis of thyclotides (R,R). The contract has no set-aside designation and was awarded on August 14, 2022 with an ultimate completion date of August 17, 2023. Frontage Laboratories, a minority-owned, Asian-Pacific American manufacturer of goods, has provided a range of research...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,890.00 on May 28, 2014, with completion due June 2, 2014. The order is firm fixed price with no set-aside designation. Work is performed in Beverly, Massachusetts. The source does not specify the goods or services being procured.</p>
The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $18,000 purchase order to Frontage Laboratories, Inc. for blood stability studies. Frontage Laboratories, the prime contractor, will perform the studies at its facility located in Exton, Pennsylvania over a two-month period concluding in early October 2018. The contract is a firm fixed price award to support the funding agency's research into diabetes, digestive diseases, and kidney disease. No subcontractors or set aside designations were identified.
Generated 12/30/23, 9:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 8/10/18 |